|
|
|
|
|
 |
The Company
Savoy Pharmaceuticals, Inc. was founded in 2004 to develop innovative therapies in the fields of oncology, virology and immunology.
Savoy’s current strategy is to develop therapies through the early phases of clinical trials and then license to or partner with large pharmaceutical companies.
- Established in 2004
- Secured US Patent established 2013
- Current estimated value – $30M
- IND submission stage for Oncoprev™ for the treatment of Liver Cancer, and Viroprev™ for the treatment of HIV and Hepatitis C.
To date, significant accomplishments have been made including; pre-clinical trials, developing a human antibody,
building investor partnerships and scientific advisory board, securing patents and identifying a CRO
(contract research organization) to submit the IND (initial new drug) application and begin clinical trials.
|
|
|
|
